DMC Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,165
Closed -$252K 122
2024
Q1
$252K Sell
3,165
-1,900
-38% -$145K 0.22% 112
2023
Q4
$400K Sell
5,065
-1,217
-19% -$86.6K 0.38% 82
2023
Q3
$439K Sell
6,282
-1,200
-16% -$85K 0.41% 74
2023
Q2
$517K Buy
7,482
+1,068
+17% +$76K 0.52% 62
2023
Q1
$488K Buy
6,414
+130
+2% +$10.9K 0.49% 66
2022
Q4
$584K Sell
6,284
-52
-0.8% -$5.02K 0.66% 47
2022
Q3
$619K Buy
6,336
+76
+1% +$7.52K 0.75% 42
2022
Q2
$585K Buy
6,260
+559
+10% +$54.6K 0.69% 45
2022
Q1
$580K Sell
5,701
-587
-9% -$61.7K 0.65% 48
2021
Q4
$671K Buy
+6,288
New +$581K 0.58% 51

Other funds holding CVS

DMC Group's CVS Position: Q2 2024 in Review

DMC Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,165 shares — an estimated $252K sold.

DMC Group first reported a position in CVS in Q4 2021 and held it in 10 quarters. The position peaked at $671K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • DMC Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • DMC Group sold 3,165 CVS Health shares in Q2 2024, an estimated $252K.
  • DMC Group first reported a position in CVS Health in Q4 2021 and held it in 10 quarters.
  • DMC Group's CVS Health position peaked at $671K in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on DMC Group's 13F filing for Q2 2024, filed 16 Jul 2024.